Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Teva Pharma Industries Ltd ADR (TEVAN)

Mexico
Currency in MXN
Disclaimer
220.25
0.00(0.00%)
Closed

TEVAN Price Commentary

great news from teva
Tevs to sell one of its row matirial fore pharma idastrial probably this year for estomation 2or3bilion.good lucke
No more shorets on teva its defenetly will rocket.
Teva real public share oloer company.
Teva biosimilar using AI technology.
300milion medications evry single day.
Teva provids more than 300medications evry single day .
wha does it taike to deliver 200 milion people evry dsy madicstion.
were is the clever bilioner to maike teva like tesla.
less is more.
Teva to rech 19
teva is sabout to sell one frvtory income astimation 2.5bilion
acording to analists teva very chip .with groth potential.
Teva has to reac 19
The best investment
Teva 125years of developing new drugs bigest jeneic company andto be leader in biosimilar drugs.
Teva free cash flew aoutsyrnding
24.02.24 Alboteck and teva .Humira biosimilar on the top of the day.from FDA.finally.
Freecash is very intresting???
Very atractiv ???
Teva revenew my hope will be more than 17.5bilions.
If your stock is dawn its probably a time to by more.
Concidering to sturting by back .
The humira biosomilar wil be agaim changer
jaint phrma is nomber one in tell aviv stock.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.